(Total Views: 514)
Posted On: 05/05/2020 10:46:40 AM
Post# of 153773
Thanks Sunny for finding and sharing this important manufacturing related news!
What struck me mostly is the following from Dr. Pourhassan:
Pourhassan is by the book, wants to dot every i and cross every t... and seems from what he's repeatedly stated, has great concern about... even regard for... regulatory processes such as those with the FDA.
I hear him over and over again compliment and appreciate how this one all important regulatory body for Leronlimab is working WITH CytoDyn and even giving the company preferential treatment (on the May 1st CC, Pourhassan answered question regarding competition "Will let Dr. Fauci and Gilead speak about Gilead... they weren't given any special privileges... we were given special privileges).
What struck me mostly is the following from Dr. Pourhassan:
Quote:
"Aji Bio-Pharma's drug product experience, infrastructure and strong regulatory track record were important to this partnership and in the timely supply of this therapeutic."
Pourhassan is by the book, wants to dot every i and cross every t... and seems from what he's repeatedly stated, has great concern about... even regard for... regulatory processes such as those with the FDA.
I hear him over and over again compliment and appreciate how this one all important regulatory body for Leronlimab is working WITH CytoDyn and even giving the company preferential treatment (on the May 1st CC, Pourhassan answered question regarding competition "Will let Dr. Fauci and Gilead speak about Gilead... they weren't given any special privileges... we were given special privileges).
(1)
(0)
